Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides-Reference-Cited by-同舟云学术

Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides

Published:2010-05-24 Issue:3 Volume:334 Page:682-692
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Kim Byung-Joon,Zhou Jie,Martin Bronwen,Carlson Olga D.,Maudsley Stuart,Greig Nigel H.,Mattson Mark P.,Ladenheim Ellen E.,Wustner Jay,Turner Andrew,Sadeghi Homayoun,Egan Josephine M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference49 articles.

1. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men

2. Exendin-4, a GLP-1 receptor agonist, modulates the effect of macronutrients on food intake by rats;Aziz;J Nutr,2002

3. A Recombinant Human Glucagon-Like Peptide (GLP)-1–Albumin Protein (Albugon) Mimics Peptidergic Activation of GLP-1 Receptor–Dependent Pathways Coupled With Satiety, Gastrointestinal Motility, and Glucose Homeostasis

4. An Albumin-Exendin-4 Conjugate Engages Central and Peripheral Circuits Regulating Murine Energy and Glucose Homeostasis

5. β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Potent STT3A/B Inhibitors and Assessment of Their Multipathogen Antiviral Potential and Safety;Journal of Medicinal Chemistry;2024-08-13

2. Development of an enabling platform biotechnology for the production of proteins;Biological Chemistry;2024-06-26

3. Transferrin levels are associated with malnutrition markers in hemodialysis patients in KwaZulu-Natal, South Africa;Renal Failure;2024-04-14

4. Protein sialylation affects the pH-dependent binding of ferric ion to human serum transferrin;Dalton Transactions;2024

5. Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment;Diabetes, Metabolic Syndrome and Obesity;2024-01